Ongoing challenge of optimal patient selection for CNS prophylaxis in patients with non-Hodgkin lymphoma

    loading  Checking for direct PDF access through Ovid

Abstract

SUMMARY

CNS relapse is a devastating and frequently lethal complication in patients with lymphoma, and selecting patients to receive CNS-directed prophylaxis is a common and frequently challenging decision for the clinician. Histologic subtype, anatomic location, molecular and clinical risk factors may all be used to stratify patients for CNS risk. In this paper we focus on these issues and attempt to provide practical guidance for the clinician in selecting which patients with lymphoma may benefit from CNS prophylaxis.

Related Topics

    loading  Loading Related Articles